Metabolic dysfunction-associated fatty liver disease (MAFLD) and type 2 diabetes (T2D) are
interconnected metabolic disorders with significant health implications. However, a …

Abstract Background and Aims Metabolic-associated fatty liver disease (MAFLD) was
proposed as a better definition of nonalcoholic fatty liver disease (NAFLD) to encompass the …

Abstract Background & Aims Metabolic dysfunction-associated fatty liver disease (MAFLD) is
a new terminology updated from non-alcoholic fatty liver disease (NAFLD). In this study, we …

Abstract Background and Aims Metabolic dysfunction‐associated steatotic liver disease
(MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), is common and …

Background Non-alcoholic fatty liver disease (NAFLD) and metabolic-associated fatty liver
disease (MAFLD) shares common pathophysiological mechanisms with type 2 diabetes …

With the increasing prevalence of obesity and type 2 diabetes, fatty liver disease associated
with metabolic dysfunction is a global health problem, especially because it is one of the …

Background Given the escalating epidemic of obesity and diabetes coupled with redefined
diagnostic criteria, it is critical to identify the prevalence of metabolic dysfunction-associated …

ABSTRACT Introduction Metabolic syndrome (MetS) is a cluster of cardio-metabolic
dysfunctions characterised by increased fasting plasma glucose, waist circumference, blood …

Background: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a globally
prevalent and multifaceted liver disorder, closely linked to metabolic conditions such as …

Introduction Metabolic syndrome (MetS) is a cluster of cardio-metabolic dysfunctions
characterised by increased fasting plasma glucose, waist circumference, blood pressure …